Tissue Regenix
 appoints non-executive director

pharmafile | July 11, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing tissue regenix 

Regenerative medical devices firm Tissue Regenix has appointed Randeep Singh Grewal as its non-executive
 director of the Group.

Grewal has 15 years’ experience working in the institutional investment
arena and, until December 2012, was a senior portfolio manager and
member of the European equities team at F&C Asset Management.

He
has also held investment analyst and portfolio management roles at ICAP
Equities and Tudor Capital, where he spent 10 years covering and
investing in healthcare companies.

Advertisement

Grewal has considerable
entrepreneurial expertise, having been involved in a number of start-up
companies, both personally and as an investor, and qualified in Medicine
from the University of Cambridge.

John Samuel, executive chairman of Tissue Regenix, said: “We are
delighted that Randeep is joining the Tissue Regenix Board and he joins
us at an exciting time. We are confident that his insight from an
investment community perspective, as well as his in-depth knowledge and
analysis of the healthcare sector, will play an invaluable role in
allowing the Group to progress further in delivering our focused
strategy.”

Related Content

No items found
The Gateway to Local Adoption Series

Latest content